Supplementary Figure S3 from Characteristics of a CCL21 Gene–Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non–Small Cell Lung Cancer
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure S3. Viability and cytokine secretion of thawed CCL21-DC vaccines.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4407145692
